Details for New Drug Application (NDA): 215081
✉ Email this page to a colleague
The generic ingredient in LIFITEGRAST is lifitegrast. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the lifitegrast profile page.
Summary for 215081
| Tradename: | LIFITEGRAST |
| Applicant: | Micro Labs |
| Ingredient: | lifitegrast |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 5% | ||||
| Approval Date: | Aug 4, 2023 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
